Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) announced today
that it has asked the United States District Court for the Central
District of California to set an expedited schedule for discovery and a
motion for a preliminary injunction against Valeant Pharmaceuticals
(NYSE: VRX) (“Valeant”), Pershing Square Capital Management, L.P.
(“Pershing Square”), and its principal, William A.
for Allergan to Request California Federal Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading Laws investment picks